Literature DB >> 19211227

Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

John M Starr1, Andrew J Farrall, Paul Armitage, Brian McGurn, Joanna Wardlaw.   

Abstract

Blood-brain barrier (BBB) dysfunction may contribute to the risk of Alzheimer's disease (AD). Dynamic contrast-enhanced magnetic resonance imaging (MRI) was performed repeatedly nine times before and up to 30 min following a 20 ml Gd-DTPA bolus injection in 15 AD participants and 15 healthy older people. For each participant, small circular regions of interest (size: 9 voxels) were placed to sample widely the deep gray matter (12 regions), cortical gray matter (72 regions), white matter (72 regions) and CSF (8 regions) as well as the basilar and internal carotid arteries (3 regions). Data were analysed using mixed effects models. There was no overall significant difference for AD subjects versus controls, but there was a significant effect for the time-by-AD interaction. Estimated marginal means remained essentially unchanged in AD subjects, but increased slowly after 15 min in healthy controls. An initial rise in gray matter MRI signal intensity followed by a later increase was also seen in AD participants after adjusting for CSF MRI signal intensities. The data suggest that BBB permeability is present even at an early stage of AD. Though the extent of leakage was no greater than that of non-demented people of a similar age in this small sample, the temporal pattern differed, indicating different blood-brain-CSF compartmental kinetics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211227     DOI: 10.1016/j.pscychresns.2008.04.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  72 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.

Authors:  Wei-Ye Liu; Zhi-Bin Wang; Li-Chao Zhang; Xin Wei; Ling Li
Journal:  CNS Neurosci Ther       Date:  2012-06-12       Impact factor: 5.243

Review 3.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

4.  The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.

Authors:  Whitney Wharton; James H Stein; Claudia Korcarz; Jane Sachs; Sandra R Olson; Henrik Zetterberg; Maritza Dowling; Shuyun Ye; Carey E Gleason; Gail Underbakke; Laura E Jacobson; Sterling C Johnson; Mark A Sager; Sanjay Asthana; Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping.

Authors:  Saeid Taheri; Charles Gasparovic; Nadim Jon Shah; Gary A Rosenberg
Journal:  Magn Reson Med       Date:  2010-12-13       Impact factor: 4.668

6.  Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.

Authors:  Stig P Cramer; Henrik B W Larsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-30       Impact factor: 6.200

Review 7.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 8.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

Review 9.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

10.  Serum levels of S100B and NSE proteins in Alzheimer's disease patients.

Authors:  Márcia L Chaves; Ana L Camozzato; Eduardo D Ferreira; Isabel Piazenski; Renata Kochhann; Oscar Dall'Igna; Guilherme S Mazzini; Diogo O Souza; Luis V Portela
Journal:  J Neuroinflammation       Date:  2010-01-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.